|
Hongrui Liu, Associate Professor
Fudan University, Pharmaceutical Sciences
Area of Focus
Cardiovascular | Pharmacology | Heart | Blood Vessels | Drugs | Cancer | Tumor | Chemotherapy | Apoptosis | Cell Cycle |
|
Wenfu Tan, Researcher
Fudan University, Pharmaceutical Sciences
Area of Focus
Anti-Tumor | Drug Activity | In Vitro | In Vivo | Evaluation | Molecular Targeted | Drug Development | Pharmacology | Cancer | Therapy |
|
Ke Yu, Researcher, Doctoral Supervisor
Fudan University, Pharmaceutical Sciences
Area of Focus
Cancer | Targeted Therapy | Innovative Drugs | Signaling Pathways | Kinases | Cell Surface Receptors | Tumor Metabolism | Small Molecules | Monoclonal Antibodies | Drug Development |
|
Zhiruo Zhou, Instructor
Fudan University, Pharmaceutical Sciences
Area of Focus
Traditional Chinese Medicine | Herbal Medicine | Pharmacology | Cancer | Diabetes | Inflammation | Tumor Microenvironment | Pulmonary Fibrosis | Photothermal Therapy | G Protein-Coupled Receptor |
|
Bo Yang, Professor, Doctoral Supervisor, Deputy Secretary of the Party Committee and Vice President of Zhejiang University City College
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Tumor | Pharmacology | Drug Mechanism | Innovative Drugs | Target Discovery | Protein Homeostasis | Toxicity Intervention | Cancer Research | Drug Development | Clinical Trials |
|
Meidan Ying, Professor, Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Tumor | Pharmacology | Cancer | Drug Targets | Pediatric | Malignant | Innovative Drugs | Research | Mechanisms | Regulation |
|
Xiaoyuan Lian, Professor | Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Traditional Chinese Medicine | Pharmacology | Neuropharmacology | New Drug Development | Ginsenosides | Parkinson'S Disease | Epilepsy | Cancer | Stem Cells | Neuroprotection |
|
Yichen Xu, Hundred Talents Program Researcher, Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Tumor | Pharmacology | Mrna | Translation | Regulation | Mechanism | Drug | Targeting | Cancer | Therapy |
|
Wei Xie, Researcher, Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Nucleic Acid Recognition | Anti-Infection | Anti-Tumor | Pharmacology | Immune Response | Drug Targets | Molecular Intervention | Mechanism Of Action | Drug Discovery | Molecular Mechanisms |
|
Jiajia Wang, Distinguished Researcher | Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Neuropharmacology: Multiple Sclerosis | Stroke | Spinal Cord Injury | Peripheral Nerve Injury | Demyelination | Pathogenesis | Intervention Strategies | Neurotoxicity | Immune Cells | Autoimmunity | Immunopharmacology: Macrophages | Dendritic Cells | Autoimmune Diseases | Immunotoxicity | Drug Targets | Molecular Mechanisms | Therapeutic Strategies | Neuro/Immunotoxicology: Clinical Drugs | Research | Clinical Studies | Drug Safety | Toxicology | Pharmacology |
